Responses
Regular and Young Investigator Award Abstracts
Clinical Trials Completed
366 Combined exploratory immunophenotyping and transcriptomic tumor analysis in patients treated with OSE2101 vaccine in HLA-A2+ advanced non-small cell lung cancer (NSCLC) from the ATALANTE-1 trial
Compose a Response to This Article
Other responses
No responses have been published for this article.